A B S T R A C T Electrophysiological studies were performed in 16 patients before and 30 min after intravenous administration of ouabain (0.1 mg/kg). P-A interval (mean+SEM) was 40±2.1 ms before and 44± 1.5 ms after ouabain (P <0.001). Atrial effective and functional refractory periods (ERP and FRP) were measured in all patients during sinus rhythm and during driving at equivalent paced rates in 12 patients. The mean atrial ERP and FRP during sinus rhythm were, respectively, 244± 10.5 and 307± 11.0 ms before and 253±9.7 and 318±11.4 ms after infusion of ouabain (NS). Mean atrial ERP and FRP during driving were, respectively, 231±15.3 and 264±14.9 ms before and 266±+18.6 and 296±+19.7 ms after ouabain (P < 0.01 and P <0.01). Mean sinus cycle length and sinus recovery times were, respectively, 887±31.2 and 1,113-+-38.7 ms before and 905+±38.2 and 1,008+30.7 ms after infusion of ouabain (NS and P < 0.005). Calculated sinoatrial conduction times before and after ouabain were 90±6.8 and 110±8.5 ms, respectively (P < 0.005).
INTRODUCTION
Experimental studies in animals and man suggest that digitalis depresses atrioventricular nodal conduction without effect on intraventricular condition (1) (2) (3) (4) (5) .
There is limited data available concerning the effects of digitalis on atrium and sinus node. Studies in intact
Received for publication 24 February 1975 and in revised form 29 April 1975. canines have demonstrated a negative chronotropic effect of digitalis on sinus node with slowing of intraatrial conduction and shortening of atrial refractory periods (1, 2, (6) (7) (8) . Engel and Schaal (9) found no demonstrable effects of ouabain on sinus node automaticity and intra-atrial conduction in patients with sick sinus syndrome. Preliminary reports by Bond, Engel, and Schaal (10, 11) suggest that digitalis prolongs calculated sinotrial conduction time in man. Reiffel, Bigger, and Giardina (12) , in another preliminary report, described variable effects on calculated sinoatrial conduction time in patients with sinus bradycardia after ouabain administration. Data concerning the effects of digitalis on human atrial refractory periods are not available.
In the present study we have used atrial stimulation techniques to systematically examine the effects of ouabain on human atrium and sinus node. Our results suggest that ouabain slows intra-atrial conduction with prolongation of atrial effective and functional refractory periods. In addition, ouabain prolongs calculated sinoatrial conduction time and decreases sinus node recovery time without significant change in spontaneous sinus rate.
METHODS
The study group consisted of 16 patients undergoing electrophysiological studies because of intraventricular conduction defects (six patients), recurrent palpitation (eight patients), or recurrent dizziness (two patients). In all patients, electrocardiographic tape recorder monitoring (Holter Dynamic EKG System, Avionics Research Products, Los Angeles, Calif.) had no demonstrated paroxysmal tachyarrhythmia, severe sinus bradycardia (heart rates of 55/min or slower), sinoatrial block, or sinus arrest. In addition, electrophysiological studies did not demonstrate induction of paroxysmal tachycardia, prolonged sinus recovery time, or prolonged calculated sinoatrial conduction time (13, 14) . There were 10 males and 6 females with ages ranging from 27 to 80 yr (mean±SEM 51+4.0 yr) ( Table I ). All patients were in sinus rhythm, had normal P-R intervals, and none were on cardiac medication at the time of study.
Informed written consent was obtained from all subjects. His bundle electrograms were recorded using previously described catheter techniques (13) . A quadripolar catheter was positioned at the high right atrium near the vicinity of sinus node for atrial pacing (two poles) and for recording high right atrial electrograms (two poles). Recordings were obtained on a multichannel oscilloscopic photographic recorder (DR-20, Electronics for Medicine, White Plains, N. Y.) at paper speeds of 100 and 200 mm/s. Simultaneous electrocardiographic leads I, II, III, and V1 were also recorded. P-A interval (normal 9-45 ms) was measured from the onset of the P wave to the first rapid deflection of the low right atrial electrogram recorded from the His bundle catheter, reflecting conduction time from high to low right atrium (13) . If the onset of the P wave could not be well delineated, the onset of the high right atrial electrogram was utilized. The measurements of P-A interval were made at 200 mm/s paper speed and reflect the average of 10 consecutive beats.
Atrial pacing was performed at increasing rates. Sinus node recovery time was defined as the interval between the last paced P wave to the first spontaneous P wave after sudden cessation of pacing at a rate of 130/min. (13) . Three sinus recovery times were determined and then averaged in each patient. Effective and functional refractory periods of the atrium were measured with atrial extrastimulus technique during sinus rhythm, as previously described (15) . The following definitions were used in regard to atrial refractory periods: A1 was the atrial electrogram of spontaneous sinus or driven beats (Si), while A2 was the atrial electrogram in response to the extra-stimulus (S2) . The atrial effective refractory period was the longest S1-S2 interval at which S2 did not result in atrial capture. The atrial functional refractory period was the shortest attainable propagated A1-A2 interval. In 12 patients, a driven cycle length approximately 20-25% faster than the sinus rate was also utilized so that refractory periods could be measured at identical cycle lengths before and after administration of ouabain.
Sinus node responses to atrial extra stimuli (A2) were categorized into four types of responses by noting the occurrence of first spontaneous sinus beat (A8) following A2 (14, [16] [17] [18] [19] (a) Nonreset due to sinus interference was defined when A3 occurred at an A2-As interval of more than spontaneous sinus cycle (Al-Al) and A1-A8 equalled 2 X A,-Al (Zone 1 response) (16); (b) Sinus reset was defined when A2-A3 was either equal to or more than A1-A1, and A1-As was less than twice A,-A, (Zone 2 response) (16); (c) Sinus interpolation was defined when A2-A3 was less than A,-A,, and A1-As was either equal to A,-Al (complete interpolation) or more than A,-Al (incomplete interpolation); (d) Sinus echoes were defined when A1-As interval was less than Al-A,, and P wave morphology of A3 approximated that of the normal P wave with a high to low sequence of atrial activation.
Each patient was categorized as to whether or not he had the above zones of nonreset due to interference, reset, interpolation, and echoes. In each patient, a zone could be defined by its longest and shortest A1-A2 coupling interval and in terms of its absolute duration. When considering all patients with a given zone, the zone could be described in terms of its mean longest and shortest A1-A2 coupling intervals as well as in terms of its mean absolute duration. Sinoatrial conduction time was calculated utilizing atrial extra stimulus technique (16, 18, 19) . For each patient, this was obtained by measuring the difference between A2-A3 and A1-A1 interval during reset and dividing by two. A mean sinoatrial conduction time was calculated for each patient using all reset responses.
Ouabain was administered intravenously in a dose of 0.01 mg/kg to each patient after control recordings. Electrophysiological studies were initiated approximately 30 min after the infusion. Statistical analysis of data was performed using the student t test for paired values. (Tables II and III) . P-A interval was measured in all patients. The mean P-A interval+SEM was 40±2.1 ms before and 44±1.5 ms after administration of ouabain (P < 0.001). Atrial effective and functional refractory periods (ERP and FRP)' were measured in all patients during sinus rhythm. The mean atrial ERP was 244±+10.5 ms before and 253±9.7 ms after administration of the drug (NS). The mean atrial FRP was 307±11.0 ms before and 318±11.4 ms after ouabain (NS). The mean atrial ERP at identical driven cycle lengths in 12 patients was 231±15.3 ms before and 266±18.6 ms after drug administration (P < 0.01) (Fig. 1) . The mean FRP of the atrium at identical driven cycle length was 264+-14.9 ms before and 296±+19.7 ms after administration of ouabain (P < 0.01) (Fig. 1) in P wave duration or morphology was noted after infusion of ouabain.
RESULTS
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Sinus rate and recovery times (Table II and III) . The mean cycle length during sinus rhythm was 887± Sinus responses to extra stimulus. A zone of interference was defined in all 13 patients in whom the extra stimulus (S2) was delivered late in sinus cycle. The mean zone of interference in these patients was between 860 (outer limit) and 708 ms (inner limit) with an absolute duration of 152 ms at a mean sinus cycle length of 860 ms. The zone increased significantly after ouabain administration, ranging from 890 (outer limit) to 632 ms (inner limit) with an absolute duration of 258 ms at a mean sinus cycle of 890 ms (P < 0.005) (Fig. 2) . This zone accounted for the last 18% of the sinus cycle length before ouabain and 28% of sinus cycle length after ouabain (P < 0.005).
The effect of ouabain on sinus reset responses was evaluated in all 16 patients. The mean zone of reset in these patients was between 716 (outer limit) and 342 ms (inner limit) before ouabain, with an absolute duration of 374 ms. The mean zone of reset after ouabain was between 657 (outer limit) and 359 ms (inner limit), with an absolute duration of 298 ms (P < 0.005) (Figs.  2 and 3) . The zone of reset accounted for 41% of sinus cycle length before and 32% after ouabain (P < 0.005).
Sinus interpolation (total or partial) was defined in four patients before ouabain administration. In two of these patients, interpolation responses were abolished with ouabain. In the remaining two patients there was no significant change in the zone of interpolation with ouabain. One patient developed interpolation responses only after ouabain. The effect of ouabain on sinus echoes was similar to that of interpolation. Sinus echo zones were present in three patients before drug administration. Ouabain abolished the sinus echo responses in one of these. In the other two patients there was no significant change in the zone of sinus echo after ouabain infusion.
Calculated sinoatrial conduction time. The effect of ouabain on calculated sinoatrial nodal conduction time was evaluated in all patients (Figs. 2 and 3 ). Mean sinoatrial conduction time was 90±6.8 ms before and 110±8.5 ms after administration of ouabain (P < 0.005).
DISCUSSION
Experimental dog studies by Mendez and Mendez (1) revealed that ouabain shortened atrial refractory periods in innervated hearts and lengthened these in denervated hearts. In another study, Mendez and Mendez (2) demonstrated a slowing of atrial conduction velocity with digitalis despite decrease in atrial refractory periods.
There are limited data available in man regarding the effect of ouabain on intra-atrial conduction with no in- At a coupling interval of 310 ms, S2 is conducted to the atrium. The A,-A2 interval is 360 ms and is the shortest attainable A1-A2 interval, defining the functional refractory period of the atrium before administration of ouabain. The atrial latency at this coupling interval is 50 ms. (B) S2 fails to capture the atrium at a coupling interval of 295 ms. This defines the effective refractory period of the atrium before ouabain. (C) At a coupling interval of 390 ms, S2 is conducted to the atrium. The Al-A2 coupling interval is 420 ms and is the shortest attainable A,-A2 interval, defining the functional refractory period of the atrium after administration of ouabain. The atrial latency of 30 ms is less than before ouabain administration. This reflects the fact that the atrial functional refractory period was achieved at a longer St-S2 coupling interval after ouabain. formation available concerning the effect on atrial effective and functional refractory periods. Engel and Schaal (9) demonstrated no significant change in P-A interval after administration of ouabain in nine patients with sick sinus syndrome. In contrast, our results suggest that ouabain depresses intra-atrial conduction as evidenced by a slight but statistically significant increase in P-A interval. In addition, ouabain significantly increased atrial functional and effective refractory periods at equivalent driven cycle lengths.
Ten Eick and Hoffman (6) and also Scherlag, Abelleira, Narula, and Samet (7) demonstrated a negative chronotropic effect of ouabain on the sinus node in intact animal hearts. Engel and Schaal (9) observed no appreciable effect of ouabain on the sinus rate in 14 patients with sinus node disease. The data from our study are in agreement with the observations of Engel and Schaal. Sinus rates were not changed significantly with ouabain administration in our patients.
Preliminary observations in our laboratory (unpublished) suggest that atropine facilitates atrial conduction in man. The effects of ouabain in this study are opposite and are thus consistant with a vagally mediated digitalis effect. We cannot exclude the presence of direct atrial effects of ouabain.
Sinus node responses to atrial extrastimuli have been recently categorized in both animals and man (14, (16) (17) (18) (19) . Responses described include nonreset due to interference of impulses delivered late in the sinus cycle, reset, interpolation, and sinus echoes. In patients without sinus node disease, nonreset and reset zones are universally present (14) . Zones of interpolation and echo are much less common (14) .
Data concerning the effects of ouabain on these sinus node responses in man are limited to preliminary reports concerning the effect of this agent on calculated sinoatrial conduction time (calculated during the zone of reset) (10-12). Bond and coworkers (10, 11) described a 53 ms lengthening of sinoatrial conduction time after ouabain administration in five patients. Reiffel et al. (12) , studying 10 patients with sinus bradycardia, demonstrated shortening of sinoatrial conduction time in 5 and lengthening in 3 patients after ouabain administration, with a mean change ranging from -22 to + 37 ms. Calculated sinoatrial conduction time was not affected in the two remaining patients. The results of the present study, a significant increase in calculated S-A conduction after ouabain administration, is in agreement with preliminary reports of Bond and associates.
The zone of interference, which represents a period late in atrial diastole in which the incoming impulse (S2) collides (probably in the perisinuous tissue) with the outgoing impulse (sinus beat) causing nonreset of the sinus node, was lengthened after administration of ouabain in our patients. Since the magnitude of this zone is approximately twice the sinoatrial conduction time, prolongation of the latter would lengthen the zone of interference (14) . Prolongation of sinoatrial conduction time and the zone of nonreset due to interference with ouabain may reflect increased refractoriness of the perinodal fibers surrounding the sinus node (17, 20) .
In the present study, the zone of reset was contracted after the infusion of ouabain. This appeared to reflect encroachment of the outer limit due to a lengthened zone of interference and encroachment of the inner limit due to prolongation of atrial functional refractory period.
Zones of interpolation (unidirectional sinus entrance block) and echoes probably reflect refractoriness of perinodal fibers (14, 17, 20) . Theoretically, ouabain should have potentiated demonstration of these zones, since the drug probably depresses perinodal conduction as suggested by prolongation of sinoatrial conduction time. The lack of this potentiation may have reflected the simultaneous increase in atrial functional refractory period, protecting the sinus node and perinodal fibers from impulses occurring at close coupling intervals.
Previous workers demonstrated a decrease in sinus node recovery time in patients wtih sinus node disease receiving ouabain (9) . In the present study, we have found a similar shortening of the sinus recovery time with ouabain in patients without clinically diagnosed sinus node disease. The abbreviation of sinus recovery time after ouabain could be due to increased refractoriness of perinodal fibers, allowing fewer driven atrial impulses to penetrate the sinus node (sinus entrance block) resulting in pseudoshortening of recovery time.
Clinical implications. Acute intravenous administration of ouabain produced slight but statistically significant slowing of intra-atrial conduction and increased atrial effective and functional refractory periods. The most important finding in our study was the increase in sinoatrial conduction time and zone of interference. This probably reflected a direct or vagally mediated effect of ouabain on perinodal fiber conduction.
These electrophysiological effects of ouabain, in addition to being of pharmacological interest, may relate to some of the electrocardiographic manifestations of digitalis intoxication, e.g., sinoatrial block, sinus arrest, and atrial standstill (21) . The increase in atrial refractoriness noted with digitalis may contribute to conversion of atrial fibrillation or flutter to sinus rhythm and suggests the possibility that digitalis could be of prophylactic value in patients with these atrial dysrrhythmias. Despite recent reports stressing the safety of digitalis in patients with sinus node disease, the demonstration of prolonged sinoatrial conduction time suggests that this drug is potentially hazardous in this group of patients (22) (23) (24) .
